DeRoyal is pleased to announce that it has purchased the assets of MKMI, an Encino, California based Corporation. MKMI manufactures the patented Umbilicup™ Cord Blood Sampling System which is a safety engineered cord blood collection device used for sampling cord blood (Rh and type) without the utilization of an exposed sharp needle. The Umbilicup™ is an important addition to DeRoyal’s line of Birthing and Neonatal products as it helps reduce the chance of needle sticks and exposure to blood borne pathogens in accordance with the Needlestick Safety and Prevention Act. It also solves the problem for hospitals of providing a safe and efficient cord transportation device for further lab testing. “According to DeRoyal President & C.O.O. Bill Pittman: “This acquisition furthers our commitment to Improving Care. & Improving Business. Safe handling of human blood is a critical aspect of caregiver safety. We are 100% committed to improving the safety of our clinical customers and the integration of this acquisition greatly enhances our birthing and neonatal product line."

According to the American Nurses Association (ANA), substantial progress has been made since the passing of the Needlestick Safety and Prevention Act in 2000, however, preventable sharps injuries and blood exposures continue to occur in U.S. healthcare settings. In 2001-2002, a significant decline in sharps injury rates occurred, but since then have leveled off. In some settings, such as surgery, needlestick rates have gone up. In an increasingly complex and changing healthcare environment, we need a renewed commitment to achieve further progress.